跳至主要内容
临床试验/CTRI/2024/05/067147
CTRI/2024/05/067147已完成4 期

Evaluation of the effect of Recombinant Human Bone Morphogenic Protein-2 on crestal bone height and osseointegration around endosseous implants

Moturi Padmini Raj1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2024年6月10日最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
20
试验地点
1
主要终点
To evaluate the implant stability around implants coated with rhBMP-2 gel.

研究概览

简要总结

BMPs are growth factors, belonging to the transforming growth factor-β family, which induces new bone formation by stimulating the differentiation of multipotent cells. They are osteoinductive in nature. Though 20 types of BMP were identified, BMP-2, 7, 8 and 9 were proved effective in enhancing osteogenic activity; and BMP 2 and 7 are approved for human use promoting bone cell migration, differentiation, and proliferation to enable bone remodeling around the implant.

Patient selection will be done after the assessment of eligibility criteria. In Phase I therapy oral prophylaxis and surgical stunt fabrication will be done. And patient will be recalled after 1 week for surgical procedure.The procedure will be performed under local anesthesia using 2% lignocaine containing adrenaline 1:80,000.A midcrestal incision will be given in both cases. A mucoperiosteal flap will be elevated and osteotomy site will be prepared. In Group 1 patients, implants will be placed without rhBMP-2 gel coating and in Group 2 implants will be coated with rhBMP-2 gel. After placement, stability will be checked with RFA at baseline.Cover screw will be given following the implant placement and flaps will be approximated and sutured. Patient will be recalled after 3 months and 6 months for evaluation of  parameters like RFA and  IOPA.

.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Outcome Assessor Blinded

入排标准

年龄范围
25.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • 1.Individuals with an age group of 25-50 years of either gender.
  • 2.Presence of adequate horizontal(4-5mm) and vertical (12mm) dimensions of the alveolar bone based on CBCT.
  • 3.Presence of adequate keratinized mucosa (minimum 1 mm) in the edentulous site.
  • 4.Apparently healthy individuals.
  • 5.Individuals with bone density classified as D2 and D3 type of bone.

排除标准

  • 1.Any forms of tobacco users.
  • 2.Pregnant and lactating women.
  • 3.Subjects taking any medication which effect healing and bone metabolism.
  • 4.Individuals with parafunctional habits.
  • 5.History of radiotherapy to head and neck.

结局指标

主要结局

To evaluate the implant stability around implants coated with rhBMP-2 gel.

时间窗: Baseline and 3 months

次要结局

  • To evaluate the crestal bone level around implants coated with rhBMP-2 gel.(Baseline ,3 months and 6 months)

研究者

发起方
Moturi Padmini Raj
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Moturi Padmini Raj

Sibar Institute of Dental Sciences

研究点 (1)

Loading locations...

相似试验